<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">34812575</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>19</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1751-875X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>16</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>IET nanobiotechnology</Title>
          <ISOAbbreviation>IET Nanobiotechnol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Characterization of folic acid-functionalized PLA-PEG nanomicelle to deliver Letrozole: A nanoinformatics study.</ArticleTitle>
        <Pagination>
          <StartPage>103</StartPage>
          <EndPage>114</EndPage>
          <MedlinePgn>103-114</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1049/nbt2.12073</ELocationID>
        <Abstract>
          <AbstractText>Effective cancer treatment is currently the number one challenge to human health. To date, several treatment methods have been introduced for cancer cell targeting. Among the proposed new methods for attacking cancer cells, nanotechnology has attracted much attention. Hence, various nanocarriers have been developed for targeted delivery of available drugs and improve their effectiveness against malignant cells. The PLA-PEG functionalised with folic acid (PLA-PEG-FA) is one of the nanocarriers with a limited range of applications for targeting cancer cells. In this investigation, different types of in-silico methods such as molecular docking approach, molecular dynamics simulation and free energy calculations are employed to characterise the carriers studied. The effectiveness of PLA-PEG-FA and PLA-PEG in delivering Letrozole as an aromatase inhibitor in cancer cells is examined. It is found that in the presence of folic acid, the stability and cell membrane permeability of nanomicelle are increased. Therefore, PLA-PEG-FA can be considered as a versatile carrier that can increase the effectiveness of aromatase inhibitors (such as Letrozole) and reduce their side effects.</AbstractText>
          <CopyrightInformation>© 2021 Arak University. IET Nanobiotechnology published by John Wiley &amp; Sons Ltd on behalf of The Institution of Engineering and Technology.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Rostami</LastName>
            <ForeName>Neda</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Chemical Engineering, Faculty of Engineering, Arak University, Arak, Iran.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Davarnejad</LastName>
            <ForeName>Reza</ForeName>
            <Initials>R</Initials>
            <Identifier Source="ORCID">0000-0002-5791-9267</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Chemical Engineering, Faculty of Engineering, Arak University, Arak, Iran.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>23</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>IET Nanobiotechnol</MedlineTA>
        <NlmUniqueID>101303205</NlmUniqueID>
        <ISSNLinking>1751-8741</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D004337">Drug Carriers</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D011091">Polyesters</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>3WJQ0SDW1A</RegistryNumber>
          <NameOfSubstance UI="D011092">Polyethylene Glycols</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>7LKK855W8I</RegistryNumber>
          <NameOfSubstance UI="D000077289">Letrozole</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>935E97BOY8</RegistryNumber>
          <NameOfSubstance UI="D005492">Folic Acid</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004337" MajorTopicYN="N">Drug Carriers</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016503" MajorTopicYN="N">Drug Delivery Systems</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005492" MajorTopicYN="Y">Folic Acid</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000077289" MajorTopicYN="N">Letrozole</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D062105" MajorTopicYN="N">Molecular Docking Simulation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D053758" MajorTopicYN="Y">Nanoparticles</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011091" MajorTopicYN="N">Polyesters</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011092" MajorTopicYN="N">Polyethylene Glycols</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Letrozole</Keyword>
        <Keyword MajorTopicYN="N">cancer</Keyword>
        <Keyword MajorTopicYN="N">cell membrane</Keyword>
        <Keyword MajorTopicYN="N">molecular dynamics</Keyword>
        <Keyword MajorTopicYN="N">nanomicelle</Keyword>
        <Keyword MajorTopicYN="N">targeted delivery</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare that there is no conflict of interest and indicate that there are no financial, personal or professional relationships with other people or organisations.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="revised">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>8</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>8</Month>
          <Day>27</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>10</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>24</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>20</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>23</Day>
          <Hour>9</Hour>
          <Minute>39</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">34812575</ArticleId>
        <ArticleId IdType="pmc">PMC9114444</ArticleId>
        <ArticleId IdType="doi">10.1049/nbt2.12073</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>

Gomari, M.M.
, et al.: CD44 polymorphisms and its variants, as an inconsistent marker in cancer investigations. Mutat. Res.
787, 108374 (2021)</Citation>
        </Reference>
        <Reference>
          <Citation>

Chaturvedi, V.K.
, et al.: Cancer nanotechnology: a new revolution for cancer diagnosis and therapy. Curr. Drug Metab.
20(6), 416–429 (2019)</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30227814</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Hazafa, A.
, et al.: CRISPR/Cas9: a powerful genome editing technique for the treatment of cancer cells with present challenges and future directions. Life Sci.
263, 118525 (2020)</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7533657</ArticleId>
            <ArticleId IdType="pubmed">33031826</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Siegel, R.L.
, 
Miller, K.D.
, 
Jemal, A.
: Cancer statistics. CA Cancer J. Clin.
69(1), 7–34 (2019)</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30620402</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Siegel, R.L.
, et al.: Cancer Statistics, 2021. CA Cancer J. Clin.
71(1), 7–33 (2021)</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">33433946</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Mattiuzzi, C.
, 
Lippi, G.
: Current cancer epidemiology. J. Epidemiol. Glob. Health. 9(4), 217–222 (2019)</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7310786</ArticleId>
            <ArticleId IdType="pubmed">31854162</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Deli, T.
, 
Orosz, M.
, 
Jakab, A.
: Hormone replacement therapy in cancer survivors—review of the literature. Pathol. Oncol. Res.
26(1), 63–78 (2020)</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7109141</ArticleId>
            <ArticleId IdType="pubmed">30617760</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Saha, T.
, et al.: Estrogen signaling: an emanating therapeutic target for breast cancer treatment. Eur. J. Med. Chem.
177, 116–143 (2019)</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31129450</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Peters, A.
, 
Tadi, P.
: Aromatase Inhibitors. StatPearls Publishing, Treasure Island:  (2021)</Citation>
        </Reference>
        <Reference>
          <Citation>

Samavat, H.
, 
Kurzer, M.S.
: Estrogen metabolism and breast cancer. Cancer Lett.
356(2 Pt), 231–243 (2015)</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4505810</ArticleId>
            <ArticleId IdType="pubmed">24784887</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Thorat, M.A.
, 
Balasubramanian, R.
: Breast cancer prevention in high‐risk women. Best Pract. Res. Clin. Obstet. Gynaecol.
65, 18–31 (2020)</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31862315</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Bell, S.G.
, et al.: Aromatase inhibitor use, side effects and discontinuation rates in gynecologic oncology patients. Gynecol. Oncol.
159(2), 509–514 (2020)</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8036903</ArticleId>
            <ArticleId IdType="pubmed">32847676</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Cottu, P.
, et al.: Letrozole and palbociclib versus chemotherapy as neoadjuvant therapy of high‐risk luminal breast cancer. Ann. Oncol.
29(12), 2334–2340 (2018)</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30307466</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Im, S.A.
, et al.: Palbociclib plus letrozole as first‐line therapy in postmenopausal Asian women with metastatic breast cancer: results from the phase III, randomized PALOMA‐2 study. J. Glob. Oncol.
5, 1–19 (2019)</Citation>
        </Reference>
        <Reference>
          <Citation>

Elzoghby, A.O.
, et al.: Multi‐reservoir phospholipid shell encapsulating protamine nanocapsules for co‐delivery of letrozole and celecoxib in breast cancer therapy. Pharm. Res.
34(9), 1956–1969 (2017)</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28643236</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Hemati Azandaryani, A.
, 
Kashanian, S.
, 
Derakhshandeh, K.
: Folate conjugated hybrid nanocarrier for targeted letrozole delivery in breast cancer treatment. Pharm. Res.
34(12), 2798–2808 (2017)</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29110284</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Ahmad, D.
, et al.: Rapid and sensitive liquid chromatographic method for determination of anastrozole in different polymer‐lipid hybrid nanoparticles. SLAS Technol.
26 (2021)</Citation>
        </Reference>
        <Reference>
          <Citation>

Afsharzadeh, M.
, et al.: PEG‐PLA nanoparticles decorated with small‐molecule PSMA ligand for targeted delivery of galbanic acid and docetaxel to prostate cancer cells. J. Cell Physiol.
235(5), 4618–4630 (2020)</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31674023</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Bae, Y.
, 
Kataoka, K.
: Intelligent polymeric micelles from functional poly(ethylene glycol)–poly(amino acid) block copolymers. Adv. Drug Deliv. Rev.
61(10), 768–784 (2009)</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19422866</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Fernández, M.
, 
Javaid, F.
, 
Chudasama, V.
: Advances in targeting the folate receptor in the treatment/imaging of cancers. Chem. Sci.
9(4), 790–810 (2017)</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5890329</ArticleId>
            <ArticleId IdType="pubmed">29675145</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Akbal, O.
, et al.: Folic acid conjugated Prussian blue nanoparticles: synthesis, physicochemical characterization and targeted cancer cell sensing. Colloids Surf. B Biointerfaces
187, 110655 (2020)</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31837885</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Angelopoulou, A.
, et al.: Folic acid‐functionalized, condensed magnetic nanoparticles for targeted delivery of doxorubicin to tumor cancer cells overexpressing the folate receptor. ACS Omega
4(26), 22214–22227 (2019)</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6933766</ArticleId>
            <ArticleId IdType="pubmed">31891105</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Jamshidian, M.
, et al.: Poly‐lactic acid: production, applications, nanocomposites, and release studies. Compr. Rev. Food Sci. Food Saf.
9(5), 552–571 (2010)</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">33467829</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Knop, K.
, et al.: Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives. Angew. Chem. Int. Ed. Engl.
49(36), 6288–6308 (2010)</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20648499</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Khaledian, M.
, et al.: Preparation and evaluation of doxorubicin‐loaded PLA‐PEG‐FA copolymer containing superparamagnetic iron oxide nanoparticles (SPIONs) for cancer treatment: combination therapy with hyperthermia and chemotherapy. Int. J. Nanomedicine
15, 6167–6182 (2020)</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7450214</ArticleId>
            <ArticleId IdType="pubmed">32922000</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Kim, S.
, et al.: PubChem 2019 update: improved access to chemical data. Nucleic Acids Res.
47(D1), D1102–d1109 (2019)</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6324075</ArticleId>
            <ArticleId IdType="pubmed">30371825</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Mahmoudi Gomari, M.
, et al.: Implementation of docking, molecular dynamics and free energy to investigate drug potency of novel BCR‐ABLT315I inhibitors as an alternative to ponatinib. Comput. Toxicol.
20, 100180 (2021)</Citation>
        </Reference>
        <Reference>
          <Citation>

Jo, S.
, et al.: CHARMM‐GUI 10 years for biomolecular modeling and simulation. J. Comput. Chem.
38(15), 1114–1124 (2017)</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5403596</ArticleId>
            <ArticleId IdType="pubmed">27862047</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Feller, S.E.
, 
Venable, R.M.
, 
Pastor, R.W.
: Computer simulation of a DPPC phospholipid bilayer: structural changes as a function of molecular surface area. Langmuir
13(24), 6555–6561 (1997)</Citation>
        </Reference>
        <Reference>
          <Citation>

Qi, Y.
, et al.: CHARMM‐GUI HMMM builder for membrane simulations with the highly mobile membrane‐mimetic model. Biophys. J.
109(10), 2012–2022 (2015)</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4656882</ArticleId>
            <ArticleId IdType="pubmed">26588561</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Mahmoudi Gomari, M.
, et al.: Insight into molecular characteristics of SARS‐CoV‐2 spike protein following D614G point mutation, a molecular dynamics study. J. Biomol. Struct. Dyn.
39, 1–9 (2021)</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31530244</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Trott, O.
, 
Olson, A.J.
: AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem.
31(2), 455–61 (2010)</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3041641</ArticleId>
            <ArticleId IdType="pubmed">19499576</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Jafari, D.
, et al.: Designing a chimeric subunit vaccine for influenza virus, based on HA2, M2e and CTxB: a bioinformatics study. BMC Mol. Cell Biol.
21(1), 89 (2020)</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7716444</ArticleId>
            <ArticleId IdType="pubmed">33276715</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Kohnke, B.
, 
Kutzner, C.
, 
Grubmüller, H.
: A GPU‐accelerated fast multipole method for GROMACS: performance and accuracy. J. Chem. Theory Comput.
16(11), 6938–6949 (2020)</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7660746</ArticleId>
            <ArticleId IdType="pubmed">33084336</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Daina, A.
, 
Zoete, V.
: Application of the SwissDrugDesign online resources in virtual screening. Int. J. Mol. Sci.
20(18) (2019)</Citation>
        </Reference>
        <Reference>
          <Citation>

Kleinerman, D.S.
, et al.: Implementations of Nosé–Hoover and Nosé–Poincaré thermostats in mesoscopic dynamic simulations with the united‐residue model of a polypeptide chain. J. Chem. Phys.
128(24), 245103 (2008)</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2577381</ArticleId>
            <ArticleId IdType="pubmed">18601387</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Hou, T.
, et al.: Assessing the performance of the molecular mechanics/Poisson Boltzmann surface area and molecular mechanics/generalized Born surface area methods. II. The accuracy of ranking poses generated from docking. J. Comput. Chem.
32(5), 866–877 (2011)</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3043139</ArticleId>
            <ArticleId IdType="pubmed">20949517</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Kumari, R.
, 
Kumar, R.
, 
Lynn, A.
: g_mmpbsa—a GROMACS tool for high‐throughput MM‐PBSA calculations. J. Chem. Inf. Model. 54(7), 1951–1962 (2014)</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24850022</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Motiei, M.
, 
Kashanian, S.
: Preparation of amphiphilic chitosan nanoparticles for controlled release of hydrophobic drugs. J. Nanosci. Nanotechnol.
17(8), 5226–5232 (2017)</Citation>
        </Reference>
        <Reference>
          <Citation>

Yousefpour, A.
, et al.: Interaction of PEGylated anti‐hypertensive drugs, amlodipine, atenolol and lisinopril with lipid bilayer membrane: a molecular dynamics simulation study. Biochim. Biophys. Acta
1848(8), 1687–1698 (2015)</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25960186</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Li, A.
, 
Schertzer, J.W.
, 
Yong, X.
: Molecular dynamics modeling of Pseudomonas aeruginosa outer membranes. Phys. Chem. Chem. Phys.
20(36), 23635–23648 (2018)</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6151269</ArticleId>
            <ArticleId IdType="pubmed">30191217</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Mashl, R.J.
, et al.: Molecular simulation of dioleoylphosphatidylcholine lipid bilayers at differing levels of hydration. Biophys. J.
81(6), 3005–3015 (2001)</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1301765</ArticleId>
            <ArticleId IdType="pubmed">11720971</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Thirumal Kumar, D.
, et al.: A computational model to predict the structural and functional consequences of missense mutations in O(6)‐methylguanine DNA methyltransferase. Adv. Protein Chem. Struct. Biol.
115, 351–369 (2019)</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30798937</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Jha, P.K.
, et al.: Annual Reports in Computational Chemistry (2005)</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
